An electrical & electronics engineer by qualification, Shikha Sinha has been working in the research and content domains for quite a while. Currently penning down informative pieces for page125.org, Shikha is also an active contributor on a variety of business portals spanning healthcare, ICT, renewables, etc. While she isn’t harnessing the power of the pen, Shikha loves to cook, read, and travel. She can be contacted at- [email protected] | https://twitter.com/shikhas999/
With the Fast Track designation, Iovance is likely to increase the frequency of its communication with the U.S. FDA. Reputed biotechnology company Iovance Biotherapeutics, Inc., has reportedly been granted the Fast Track designation for its adoptive cell therapy LN-145, developed using its proprietary TIL manufacturing …
The FDA will decide on the definitive approval by the 19th of August 2019. The U.S. Food & Drug Administration (FDA) has reportedly accepted the BLA (Biologics License Application) submitted by the Swiss multinational healthcare company, Roche. The company has been officially granted Priority Review …
Renowned pharmaceuticals company Pharma major Dr Reddy’s Laboratories Ltd., has reportedly brought the Propofol Injectable Emulsion to the U.S. shores. Propofol, a therapeutic generic equivalent version of Diprivan (propofol) Injectable Emulsion, has been given the green signal by the U.S. Food and Drug Administration and …
The move sets UK as the only European country to approve TIV High Dose for the prevention of influenza flu specifically amongst senior citizens. The UK has reportedly granted marketing authorization to vaccine maker Sanofi Pasteur’s TIV (Trivalent Influenza Vaccine) High Dose, a vaccine prescribed …
Imatinib Mesylate is claimed to stop the growth of cancer cells and is prescribed for treating Leukemia and certain Gastro-Intestinal tumors. Renowned pharmaceutical and biotechnology company, Wockhardt, recently received the USFDA approval for an ANDA for 100 mg and 400 mg tablets of Imatinib Mesylate. …
Perlara, the U.S. based biotech public benefit corporation that is dedicated to discovering cures for rare diseases, recently announced a partnership with Rambam Medical Center in Israel and Dr. Karl Skorecki, a leading kidney disease researcher and nephrologist, to co-develop a PerlQuest into APOL1 kidney disease. For …
The medical mobile application is specifically developed to boost patient retention at facilities that treat opioid abuse. The app is intended to be utilized alongside other treatments under a healthcare professional’s supervision. Pear Therapeutics, a renowned U.S-based biotech firm, has reportedly announced that its mobile …
Canadian smartphone maker BlackBerry Limited has reportedly declared that it has become a HIMSS Analytics Certified Consultant to assist in addressing the digital infrastructure requirements of healthcare establishments across the globe. As per trusted sources, BlackBerry would now help healthcare institutions through the stages of …
Roche, the Swiss drug manufacturer recently acquired the San Diego based startup Jecure Therapeutics for an undisclosed amount. According to sources the recent accrual is meant to help Roche join in the pursuit of discovering new drugs that can cure fatty liver disease. Other pharmaceutical …
